IA
REPL icon

IndexIQ Advisors’s Replimune Group REPL Stock Holding History

IndexIQ Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,842
Closed -$375K – 1466
2021
Q4 		$375K Sell
13,842
-894
-6% -$26.7K 0.01% 833
2021
Q3 		$437K Buy
14,736
+1,476
+11% +$47.9K 0.01% 708
2021
Q2 		$509K Buy
13,260
+547
+4% +$18.7K 0.02% 450
2021
Q1 		$388K Buy
+12,713
New +$476K 0.01% 907

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IndexIQ Advisors's REPL Position: Q1 2022 in Review

IndexIQ Advisors sold out of Replimune Group (REPL) in Q1 2022, closing a stake of 13,842 shares — an estimated $375K sold.

IndexIQ Advisors first reported a position in REPL in Q1 2021 and held it in 4 quarters. The position peaked at $509K in Q2 2021. 107 funds tracked by Wall St. Rank hold REPL as of Q1 2022.

  • IndexIQ Advisors reported no remaining Replimune Group position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 13,842 Replimune Group shares in Q1 2022, an estimated $375K.
  • IndexIQ Advisors first reported a position in Replimune Group in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Replimune Group position peaked at $509K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Replimune Group as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.